Merck Antibody Shows Promise in Reducing Deadly Diarrhea Recurrence Risk – Youth Health Magzine



Youth Health Magzine
Merck Antibody Shows Promise in Reducing Deadly Diarrhea Recurrence Risk
Youth Health Magzine
Bezlotoxumab works by binding with toxin B of the bacteria, which can cause the inflammation of the gut, which then results to watery diarrhea and abdominal pain, some of the most common symptoms of the infection. Actoxumab, on the other hand, works …
Merck antibody reduces risk of Clostridium difficile recurrence: studyReuters
Merck (MRK) Announces Two Pivotal Phase 3 Trials of Bezlotoxumab in C StreetInsider.com
Merck's antibody prevents recurrence of Clostridium difficile (Video)Nature World Report
BioWorld Online
all 21 news articles »

diarrhea – Google News